IT8847814A0 - Impieghi in terapeutica degli agonisti dei recettori dopaminergici - Google Patents
Impieghi in terapeutica degli agonisti dei recettori dopaminergiciInfo
- Publication number
- IT8847814A0 IT8847814A0 IT8847814A IT4781488A IT8847814A0 IT 8847814 A0 IT8847814 A0 IT 8847814A0 IT 8847814 A IT8847814 A IT 8847814A IT 4781488 A IT4781488 A IT 4781488A IT 8847814 A0 IT8847814 A0 IT 8847814A0
- Authority
- IT
- Italy
- Prior art keywords
- receptor agonists
- therapeutic uses
- dopamine receptor
- dopamine
- therapeutic
- Prior art date
Links
- 239000003136 dopamine receptor stimulating agent Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878708626A GB8708626D0 (en) | 1987-04-10 | 1987-04-10 | Indolophenanthridines |
GB878708898A GB8708898D0 (en) | 1987-04-14 | 1987-04-14 | Indolophenanthridines |
GB878710062A GB8710062D0 (en) | 1987-04-28 | 1987-04-28 | Indolophenanthridines |
GB878720366A GB8720366D0 (en) | 1987-08-28 | 1987-08-28 | Dopamine d1 receptor agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8847814A0 true IT8847814A0 (it) | 1988-04-05 |
IT1219906B IT1219906B (it) | 1990-05-24 |
Family
ID=27449909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT47814/88A IT1219906B (it) | 1987-04-10 | 1988-04-05 | Impieghi in terapeutica degli agonisti dei recettori dopaminergici |
Country Status (11)
Country | Link |
---|---|
US (1) | US4855306A (it) |
JP (1) | JPS63258819A (it) |
KR (1) | KR880012227A (it) |
AU (1) | AU1440088A (it) |
DE (1) | DE3811274A1 (it) |
DK (1) | DK193588A (it) |
FR (1) | FR2613623A1 (it) |
GB (1) | GB2205495A (it) |
IT (1) | IT1219906B (it) |
NL (1) | NL8800823A (it) |
SE (1) | SE8801275A0 (it) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69838789T2 (de) * | 1997-03-12 | 2008-10-30 | Suzanne Cambridge de la Monte | Verfahren zur behandlung oder prävention der alzheimerischen krankheit |
US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
US6362371B1 (en) * | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
DE10148233A1 (de) * | 2001-09-28 | 2003-04-10 | Boehringer Ingelheim Pharma | Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
CA2483464C (en) * | 2002-05-17 | 2011-12-20 | Duke University | Method for treating obesity |
DE10312809A1 (de) * | 2003-03-21 | 2004-09-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern |
US20040266794A1 (en) * | 2003-03-21 | 2004-12-30 | Boehringer Ingelheim International Gmbh | Pramipexole for the reduction of excessive food intake for children |
ES2303085T3 (es) | 2003-04-29 | 2008-08-01 | Orexigen Therapeutics, Inc. | Composiciones que afectan a la perdida de peso. |
EP1626703A2 (en) * | 2003-05-22 | 2006-02-22 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells |
US7713959B2 (en) * | 2004-01-13 | 2010-05-11 | Duke University | Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
JP2007517901A (ja) * | 2004-01-13 | 2007-07-05 | デューク・ユニバーシティー | 体重の減少に作用する鎮痙剤及び抗精神病剤の組成物 |
JP2007536229A (ja) * | 2004-05-03 | 2007-12-13 | デューク・ユニバーシティー | 体重減少に作用するための組成物 |
WO2006119353A2 (en) * | 2005-05-03 | 2006-11-09 | University Of South Carolina | Dopamine receptor agonists in the treatment and prevention of hiv-induced dementia |
BRPI0618918B8 (pt) | 2005-11-22 | 2021-05-25 | Nalpropion Pharmaceuticals Llc | uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
MX343867B (es) | 2006-11-09 | 2016-11-25 | Orexigen Therapeutics Inc | Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso. |
KR20190042766A (ko) | 2006-11-09 | 2019-04-24 | 오렉시젠 세러퓨틱스 인크. | 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형 |
MX2010012909A (es) | 2008-05-30 | 2011-02-25 | Orexigen Therapeutics Inc | Metodos para tratamiento de condiciones de grasa visceral. |
BRPI1008585B1 (pt) * | 2009-08-27 | 2020-05-12 | Daikin Industries, Ltd | Aditivo de processamento, composição de moldagem e mistura principal de ativo de processamento |
AU2011203867B2 (en) | 2010-01-11 | 2015-12-03 | Nalpropion Pharmaceuticals Llc | Methods of providing weight loss therapy in patients with major depression |
EP2858640B1 (en) | 2012-06-06 | 2020-03-25 | Nalpropion Pharmaceuticals LLC | Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3402392A1 (de) * | 1984-01-25 | 1985-08-01 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue ergolinderivate, deren herstellung und deren verwendung |
-
1988
- 1988-03-31 NL NL8800823A patent/NL8800823A/nl not_active Application Discontinuation
- 1988-04-01 FR FR8804499A patent/FR2613623A1/fr not_active Withdrawn
- 1988-04-02 DE DE3811274A patent/DE3811274A1/de not_active Withdrawn
- 1988-04-05 IT IT47814/88A patent/IT1219906B/it active
- 1988-04-07 GB GB08808125A patent/GB2205495A/en active Pending
- 1988-04-07 US US07/178,668 patent/US4855306A/en not_active Expired - Fee Related
- 1988-04-08 DK DK193588A patent/DK193588A/da not_active Application Discontinuation
- 1988-04-08 SE SE8801275A patent/SE8801275A0/sv not_active Application Discontinuation
- 1988-04-08 AU AU14400/88A patent/AU1440088A/en not_active Abandoned
- 1988-04-09 KR KR1019880004023A patent/KR880012227A/ko not_active Application Discontinuation
- 1988-04-09 JP JP63088033A patent/JPS63258819A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK193588A (da) | 1988-10-11 |
NL8800823A (nl) | 1988-11-01 |
SE8801275L (sv) | 1988-10-19 |
IT1219906B (it) | 1990-05-24 |
JPS63258819A (ja) | 1988-10-26 |
US4855306A (en) | 1989-08-08 |
AU1440088A (en) | 1988-10-13 |
KR880012227A (ko) | 1988-11-26 |
DE3811274A1 (de) | 1988-10-27 |
SE8801275D0 (sv) | 1988-04-08 |
SE8801275A0 (sv) | 1988-10-19 |
GB2205495A (en) | 1988-12-14 |
GB8808125D0 (en) | 1988-05-11 |
FR2613623A1 (fr) | 1988-10-14 |
DK193588D0 (da) | 1988-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8847814A0 (it) | Impieghi in terapeutica degli agonisti dei recettori dopaminergici | |
IT8748211A0 (it) | Impiego in terapeutica degli antagonisti dei recettori serotoninergici 5ht3 | |
DK73688D0 (da) | Flydende enzymformuleringer | |
FI881155A (fi) | Ihon lämpötilan mittauslaite perifeerisen verenkierron häiriöiden määrittämiseksi | |
IT1199411B (it) | Dispositivo per misurare l'umidita'contenuta nella pelle o simili | |
ATA74788A (de) | Schwenkarmvorrichtung | |
IT8647977A0 (it) | Impiego in terapeutica degli agonisti dopaminergici | |
IT8847906A0 (it) | Impiego in terapeutica degli agonisti dei ricettori della dopamina | |
EP0417637A3 (en) | Use of dopamine autoreceptor agonists in the treatment of drug dependency | |
DK415087D0 (da) | Terapeutiske midler indeholdende benzhydrylthiomethanderivater | |
KR920700637A (ko) | 피임을 위한 멜라토닌 유도체의 용도 | |
DE3855473T2 (de) | Hyperthermiegerät | |
ZA882478B (en) | New uses of dopamine receptor agonists | |
KR890002188U (ko) | 타올 페어퍼 호울더 | |
KR890004889U (ko) | 연사기용 실린다의 핀 출몰장치 | |
GB8720366D0 (en) | Dopamine d1 receptor agonists | |
IT8803669A0 (it) | Apparecchio ginnico di condizionamento dei muscoli adduttori per elevare il divaricamento degli arti inferiori | |
ZA903015B (en) | Therapeutic use of 5-ht3 receptor antagonists | |
KR910001604U (ko) | 플런지 업 유니트의 핀홀더 | |
KR880015613U (ko) | 스폰지 어깨패드의 가공장치 | |
KR880015612U (ko) | 스폰지 어깨패드의 가공장치 | |
IT8420572V0 (it) | Dispositivo per la valutazione degli stati dolorosi. | |
ITGE910099A1 (it) | Dispositivo optometrico, in particolare per la misurazione dell' aniseiconia, della disparita' di fissazione e dei movimenti ciclotorsionali | |
KR900010151U (ko) | 연사기용 실린더의 지지장치 | |
KR880015720U (ko) | 괘도걸이 겸용 흑판걸이 |